Drug news
NovoTTF-100A system is FDA approved for Glioblastoma
FDA recently approved the NovoTTF-100A System, a new device from Novocure Inc. to treat adults with glioblastoma multiforme (GBM) that recurs or progresses after receiving chemotherapy and radiation therapy.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.